Cue Biopharma, Inc.·4

Apr 21, 4:15 PM ET

Garzone Pamela 4

4 · Cue Biopharma, Inc. · Filed Apr 21, 2023

Insider Transaction Report

Form 4
Period: 2023-04-19
Transactions
  • Award

    Stock Option (right to buy)

    2023-04-19+40,00040,000 total
    Exercise: $3.46Exp: 2033-04-18Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION